Equasens Acquires 80% of Erevo to Accelerate Digital Training Strategy
- Acquisition of Erevo: Equasens has acquired an 80% controlling stake in Erevo, expected to generate €7.4 million in revenue by 2025, significantly enhancing its market position in healthcare professional training.
- Training Product Expansion: This acquisition integrates Erevo's online courses with Equasens' existing services, improving training quality and addressing the healthcare industry's demand for continuous education, which is anticipated to boost customer satisfaction and market share.
- Synergies Realized: Erevo's digital training solutions complement Equasens' hardware and software offerings, expected to create substantial operational and marketing synergies that support the company's growth in the rapidly evolving healthcare education market.
- Future Development Potential: By leveraging Erevo's expertise, Equasens plans to develop new AI-driven features to enhance educational effectiveness, ensuring its leadership position in the healthcare training sector.
Trade with 70% Backtested Accuracy
Analyst Views on EQS
About EQS
About the author


Equus Total Return, Inc. Funding Announcement: Equus announced that its subsidiary, Morgan E&P, has secured a $3 million term loan to fund drilling operations in the Bakken Shale formation, aiming to enhance production and cash flow by developing existing non-producing wells.
Strategic Development Plans: The funding will allow Morgan to accelerate development opportunities in both operated and non-operated acreage, with expectations of increasing production volumes and strengthening Equus' energy portfolio strategy in one of North America's key oil-producing regions.

Equus Total Return, Inc. Compliance Issue: The company received a notice from the NYSE for not meeting the minimum average closing price requirement of $1.00 for its common stock over a 30-day period, but this deficiency does not currently affect its listing or trading status.
Plans to Regain Compliance: Equus intends to notify the NYSE by May 25, 2025, of its plan to address the stock price deficiency, potentially through a reverse stock split, and has a six-month period to regain compliance with the NYSE's standards.

New Appointments at Equus Total Return, Inc.: Fraser Atkinson has been appointed as the independent Chairman of the Board and John J. May as an independent director, effective immediately. Both will serve on various committees within the Fund.
John J. May's Background: Mr. May brings over 50 years of experience as a Chartered Accountant and has held significant roles in public and private companies, particularly in mining, energy, and oil and gas sectors. He is also involved with lobbying groups representing small and medium-sized businesses in the UK.
Financial Performance: Equus Total Return, Inc. reported a decrease in net assets to $40.2 million and a decline in net asset value per share from $3.66 to $2.96 as of September 30, 2024, primarily due to decreases in the fair value of its holdings in Morgan E&P and Equus Energy.
Market Influences: The declines in fair value were attributed to a significant drop in oil prices and decreased production from operational wells, with specific losses of $7.0 million for Morgan E&P and $2.0 million for Equus Energy during the third quarter of 2024.



